Cholinesterase Reactivators

DBCAT001098Therapeutic category

Drugs used to reverse the inactivation of cholinesterase caused by organophosphates or sulfonates. They are an important component of therapy in agricultural, industrial, and military poisonings by organophosphates and sulfonates. A DrugBank category of 2 drugs. 1 of them is approved.

Also known as: Antagonists, Organophosphate Insecticide · Antagonists, Organothiophosphate Insecticide · Insecticide Antagonists, Organophosphate · Insecticide Antagonists, Organothiophosphate · Insecticides, Organophosphate, Antagonists
Drugs: Obidoxime
Pralidoxime

What you can answer from here — as of August 24, 2016

2DrugsEach linked to its full drug card

Listed above

2Drug targetsEvery drug–target pair in the class, with bond type

14Marketed productsAcross the regions we cover, with dosage forms and routes

5Routes of administrationHow the drugs in this class are given

Which targets do Cholinesterase Reactivators share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account